+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Protein Drugs"

Cell Free Protein Expression - Global Strategic Business Report - Product Thumbnail Image

Cell Free Protein Expression - Global Strategic Business Report

  • Report
  • August 2025
  • 198 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
Pharmaceutical Filtration Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Pharmaceutical Filtration Market - Forecasts from 2025 to 2030

  • Report
  • February 2025
  • 149 Pages
  • Global
From
Biologics CDMO Market Report and Forecast 2025-2034 - Product Thumbnail Image

Biologics CDMO Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
From
Loading Indicator

The Protein Drugs market is a subset of the larger Drug Discovery industry. It focuses on the development of drugs that are based on proteins, such as monoclonal antibodies, cytokines, and growth factors. These drugs are used to treat a variety of diseases, including cancer, autoimmune disorders, and infectious diseases. Protein drugs are typically developed through recombinant DNA technology, which involves the manipulation of genetic material to create a desired protein. The Protein Drugs market is highly competitive, with many companies vying for a share of the market. Companies in the market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are engaged in research and development of new protein drugs, as well as the marketing and distribution of existing drugs. Show Less Read more